Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hewei Jiangni Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for the treatment of non-erosive gastroesophageal reflux disease (NERD). Developed by researchers at the Dongfang Hospital of Beijing University of Chinese Medicine, the decoction is formulated to address the TCM pattern of "stomach qi rebellion" by harmonizing the stomach and directing qi downward. Clinical studies have compared its efficacy to proton pump inhibitors like omeprazole, focusing on its ability to alleviate symptoms such as heartburn, acid regurgitation, and chest pain while potentially offering a lower recurrence rate. The formula typically consists of multiple botanical extracts aimed at improving gastric motility and reducing esophageal mucosal sensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hewei Jiangni Decoction.